Patents Assigned to 4C Medical Technologies, Inc.
-
Patent number: 12232991Abstract: Loading systems for prosthetic heart valve devices are disclosed. A loading funnel is provided within a watertight interior space that is at least partially filled or fillable with biocompatible fluid. Funnel may have a cylindrical end to which is connected a delivery catheter having a lumen that will receive the collapsed prosthetic heart valve device. An expanded prosthetic heart valve device may be placed within the funnel and pushed or pulled into the funnel which provides a predictable, reliable and repeatable surface for collapsing the prosthetic heart valve device. Ultimately the prosthetic heart valve device is collapsed and translated into the lumen of the delivery catheter for further translation therealong and release into the heart chamber of interest.Type: GrantFiled: August 23, 2022Date of Patent: February 25, 2025Assignee: 4C Medical Technologies, Inc.Inventors: Jason S. Diedering, Saravana B. Kumar
-
Patent number: 12133797Abstract: Systems, devices and methods for attaching an operator-manipulatable tether(s) to the stent for: loading and/or collapsing the expandable stent into a delivery catheter or sheath, translating the collapsed stent along the delivery catheter or sheath, delivering the expandable stent into the subject heart chamber, repositioning the expandable stent as necessary within the subject heart chamber, recapturing or resheathing the expandable stent within the delivery catheter or sheath if needed, and deploying the expandable stent to, and within, the subject heart chamber.Type: GrantFiled: January 28, 2021Date of Patent: November 5, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Thomas Benson, Jason S. Diedering
-
Patent number: 12053375Abstract: The present invention provides a prosthetic heart valve device with improved fit and/or apposition between the device frame and left atrial tissue and/or the device base and the annular tissue of the left atrium to improve shifting of the implanted device and/or mitigate paravalvular leakage. The improved fit and/or apposition arises in various embodiments by providing or allowing an asymmetrical frame and/or frame base and/or providing a lower lip to aid in conforming to the asymmetrical shape of the atrium and/or ensure firm positioning therein. An additional benefit of these arrangement(s) is mitigation of paravalvular leakage as a result of improved fit and seal. In certain embodiments, the asymmetry of the frame assists with delivery of the device into the atrium.Type: GrantFiled: February 1, 2021Date of Patent: August 6, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Saravana B. Kumar, Steven D. Kruse, Jeffrey R. Stone
-
Patent number: 12036113Abstract: The invention relates to prosthetic heart valves comprising a stent frame with valve support disposed or inverted at least partially within the stent frame, wherein the valve support is at least partially within the interior of the stent frame. The inverted configuration comprises a maximum number of layers of material in cross section where the stent frame and valve support overlap. The maximum number of cross-sectional layers of material structure may be reduced to, e.g., two layers of material to reduce outer diameter during delivery by everting the valve portion to a position located outside of the stent portion, followed by inverted reconfiguration back to the inverted anchoring structure after delivery from the lumen of the delivery catheter to the heart chamber.Type: GrantFiled: June 13, 2018Date of Patent: July 16, 2024Assignee: 4C Medical Technologies, Inc.Inventor: Saravana B. Kumar
-
Patent number: 12029647Abstract: Devices and methods for supplementing and/or replacing native cardiac valve functionality, e.g., the mitral valve with a single prosthetic leaflet. An exemplary device is directed to dysfunctional mitral valves. In some cases, the entire device, including the single prosthetic leaflet, will be arranged entirely above the dysfunctional mitral valves and, therefore, disposed entirely within the left atrium. In other cases, the valve support and/or single prosthetic leaflet may extend a distance into the annulus between the left atrium and left ventricle. In some cases, the device will not physically interact with the native leaflets. In other cases, the device may physically interact with the native leaflets.Type: GrantFiled: March 6, 2018Date of Patent: July 9, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Jeffrey W. Chambers, Saravana B. Kumar, Joseph P. Higgins, Robert J. Thatcher, Jason S. Diedering, Jeffrey R. Stone
-
Patent number: 11992403Abstract: A collapsible and expandable prosthetic mitral valve stent is provided with improved recapture into a distal lumen of a delivery sheath. Various embodiments comprise a valve support within the interior of a stent frame and defining a flow channel therethrough, wherein the top or upstream of the valve support comprises a row, or a plurality, of stent cells that are bent radially inward at least partially over the flow channel. Some embodiments may comprise a recapture assist mechanism, such as an open paddle, attached to one or more of the inwardly bent stent cells and adapted to receive and/or engage a wire to aid in positioning, expansion, recapture and/or implanting the device in a patient's heart chamber.Type: GrantFiled: December 4, 2020Date of Patent: May 28, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Jonathan Berndt, Sounthara Khouengboua, Saravana Kumar
-
Patent number: 11957577Abstract: Embodiments of delivery systems, devices and methods for delivering a prosthetic heart valve device to a heart chamber for expanded implementation are disclosed. More specifically, methods, systems and devices are disclosed for delivering a self-expanding prosthetic mitral valve device to the left atrium, with no engagement of the left ventricle, the native mitral valve leaflets or the annular tissue downstream of the upper annular surface during delivery, and in some embodiments with no engagement of the ventricle, mitral valve leaflets and/or annular tissue located downstream of the upper annular surface by the delivered, positioned and expanded prosthetic mitral valve device.Type: GrantFiled: March 31, 2020Date of Patent: April 16, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Jeffrey W. Chambers, Gregory G. Brucker, Joseph P. Higgins, Saravana B. Kumar, Jason S. Diedering, Karl A. Kabarowski, Robert J. Thatcher, James E. Flaherty, Jeffrey R. Stone
-
Patent number: 11944537Abstract: A two-step delivery method, system and device is disclosed comprising, in various embodiments, a self-expanding frame. A self-expanding frame is delivered and expanded within a heart chamber followed by delivery of a prosthetic valve comprising prosthetic valves thereon into the expanded self-expanding frame, which is in turn connected to a valve connection region defined on and by the delivered and expanded frame.Type: GrantFiled: February 17, 2020Date of Patent: April 2, 2024Assignee: 4C Medical Technologies, Inc.Inventor: Jeffrey W. Chambers
-
Patent number: 11931253Abstract: Systems, devices and methods for attaching an operator-manipulatable tether(s) to the stent for: loading and/or collapsing the expandable stent into a delivery catheter or sheath, translating the collapsed stent along the delivery catheter or sheath, delivering the expandable stent into the subject heart chamber, repositioning the expandable stent as necessary within the subject heart chamber, recapturing or resheathing the expandable stent within the delivery catheter or sheath if needed, and deploying the expandable stent to, and within, the subject heart chamber.Type: GrantFiled: January 26, 2021Date of Patent: March 19, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Jason S. Diedering, Thomas Benson
-
Patent number: 11872127Abstract: A two-step delivery method, system and device is disclosed comprising, in various embodiments, a self-expanding frame. A self-expanding frame is delivered and expanded within a heart chamber followed by delivery of a prosthetic valve comprising prosthetic valves thereon into the expanded self-expanding frame, which is in turn connected to a valve connection region defined on and by the delivered and expanded frame.Type: GrantFiled: February 17, 2020Date of Patent: January 16, 2024Assignee: 4C Medical Technologies, Inc.Inventor: Jeffrey W. Chambers
-
Patent number: 11857441Abstract: A device and method for predictably and controlling the collapsing of a collapsible and expandable stent for subsequent translation through a delivery sheath lumen to an anatomical target such as a heart valve or intravascular location for expansion and implantation. The loading device defines in inner lumen comprising a successively decreasing, from the proximal to the distal direction, inner diameter to a region of constant inner diameter wherein the stent is in a collapsed configuration. The device and method may provide for an at least partially collapsed configuration of the stent that may be further collapsed as a part of the implantation procedure and may comprise a stent that is pre-loaded for future use.Type: GrantFiled: September 3, 2019Date of Patent: January 2, 2024Assignee: 4C Medical Technologies, Inc.Inventors: Jason S. Diedering, Saravana B. Kumar
-
Patent number: 11452628Abstract: Loading systems for prosthetic heart valve devices are disclosed. A loading funnel is provided within a watertight interior space that is at least partially filled or fillable with biocompatible fluid. Funnel may have a cylindrical end to which is connected a delivery catheter having a lumen that will receive the collapsed prosthetic heart valve device. An expanded prosthetic heart valve device may be placed within the funnel and pushed or pulled into the funnel which provides a predictable, reliable and repeatable surface for collapsing the prosthetic heart valve device. Ultimately the prosthetic heart valve device is collapsed and translated into the lumen of the delivery catheter for further translation therealong and release into the heart chamber of interest.Type: GrantFiled: April 14, 2020Date of Patent: September 27, 2022Assignee: 4C Medical Technologies, Inc.Inventors: Jason S. Diedering, Saravana B. Kumar
-
Patent number: 11351028Abstract: A device and method for predictably and controlling the collapsing of a collapsible and expandable stent for subsequent translation through a delivery sheath lumen to an anatomical target such as a heart valve or intravascular location for expansion and implantation. The loading device defines in inner lumen comprising a successively decreasing, from the proximal to the distal direction, inner diameter alternating between two sections of decreasing diameter and two sections of constant diameter until reaching the inner diameter of the delivery sheath. A fluid-filled reservoir is provided at the proximal end of the loading device that is configured to provide moisture or wetting for materials associated with or attached to the stent that require moisture retention. Thus, as the stent is being collapsed with the loading device, at least a portion of the stent may be immersed in the fluid reservoir to preserve the subject material.Type: GrantFiled: September 3, 2019Date of Patent: June 7, 2022Assignee: 4C Medical Technologies, Inc.Inventors: Alex A. Peterson, Jason S. Diedering, Saravana B. Kumar
-
Patent number: 11026782Abstract: Various embodiments of the present invention comprise a single-chamber collapsible and expandable prosthetic valve implant device with an elevated valve section and comprising the following capabilities: (1) preservation of native valve functionality; (2) initial preservation of native valve functionality with subsequent full replacement of native valve functionality; (3) full replacement of native valve functionality; and/or (4) mitigation of the prolapsing distance of the dysfunctional leaflets by preventing the anterior excursion of the prolapsing leaflets above the upper annular surface and into the left atrial chamber in order to preserve native leaflet functionality for as long as possible. The expanded and implanted device does not extend beyond the boundaries of the subject heart chamber, e.g., the left atrium, thereby enabling the preservation of any remaining native valve functionality with subsequent full replacement of native valve functionality if and when needed.Type: GrantFiled: August 10, 2017Date of Patent: June 8, 2021Assignee: 4C Medical Technologies, Inc.Inventor: Jeffrey W. Chambers
-
Patent number: 11000000Abstract: The invention provides methods, devices and systems for delivering, positioning and/or repositioning an expandable prosthetic heart valve in a patient's heart chamber. At least one non-looped wire and looped wire pair is operatively connected with an expanded prosthetic heart valve that is collapsed within a delivery catheter lumen having its distal end positioned in the subject heart chamber. The collapsed prosthetic heart valve is translated through the delivery catheter lumen to and out of its distal end where the prosthetic heart valve expands to a working configuration. The wire(s) of the non-looped and looped wire pair may be manipulated by pulling proximately or pushing distally to position or reposition the expanded prosthetic stent into position, then released from connection with the positioned stent and withdrawn from the patient.Type: GrantFiled: September 12, 2019Date of Patent: May 11, 2021Assignee: 4C Medical Technologies, Inc.Inventors: Jason S. Diedering, Saravana B. Kumar
-
Patent number: 10874513Abstract: A collapsible and expandable prosthetic heart valve stent is provided and comprising an outer section, a valve support defining a flow channel therethrough, a transition section configured to smoothly transition the outer section to the valve support. The valve support is disposed within an interior defined by the outer section, with the inflow end of the valve support disposed inside the outer section's interior. In some cases, the outflow end of the valve support is at least partially defined by the transition section. The prosthetic leaflets are disposed on the inner surface of the valve support's flow channel and are located at or above the annulus of the heart chamber. A paravalvular leakage mitigation system is attached to the stent to mitigate retrograde blood flow and/or regurgitation.Type: GrantFiled: February 11, 2019Date of Patent: December 29, 2020Assignee: 4C Medical Technologies, Inc.Inventors: Jeffrey W. Chambers, Steven D. Kruse, Saravana B. Kumar
-
Patent number: 10828152Abstract: Various embodiments of the present invention comprise a single-chamber collapsible and expandable prosthetic valve implant device comprising the following capabilities: (1) preservation of native valve functionality; (2) initial preservation of native valve functionality with subsequent full replacement of native valve functionality; (3) full replacement of native valve functionality; and/or (4) mitigation of the prolapsing distance of the dysfunctional leaflets by preventing the anterior excursion of the prolapsing leaflets above the upper annular surface and into the left atrial chamber in order to preserve native leaflet functionality for as long as possible. The expanded and implanted device does not extend beyond the boundaries of the subject heart chamber, e.g., the left atrium, thereby enabling the preservation of any remaining native valve functionality with subsequent full replacement of native valve functionality if and when needed.Type: GrantFiled: August 10, 2017Date of Patent: November 10, 2020Assignee: 4C Medical Technologies, Inc.Inventor: Jeffrey W. Chambers
-
Patent number: 10751169Abstract: Various embodiments of the present invention comprise a single-chamber collapsible and expandable prosthetic valve implant device comprising the following capabilities: (1) preservation of native valve functionality; (2) initial preservation of native valve functionality with subsequent full replacement of native valve functionality; (3) full replacement of native valve functionality; and/or (4) mitigation of the prolapsing distance of the dysfunctional leaflets by preventing the anterior excursion of the prolapsing leaflets above the upper annular surface and into the left atrial chamber in order to preserve native leaflet functionality for as long as possible. The expanded and implanted device does not extend beyond the boundaries of the subject heart chamber, e.g., the left atrium, thereby enabling the preservation of any remaining native valve functionality with subsequent full replacement of native valve functionality if and when needed.Type: GrantFiled: March 26, 2019Date of Patent: August 25, 2020Assignee: 4C Medical Technologies, Inc.Inventor: Jeffrey W. Chambers
-
Patent number: 10653523Abstract: Embodiments of delivery systems, devices and methods for delivering a prosthetic heart valve device to a heart chamber for expanded implementation are disclosed. More specifically, methods, systems and devices are disclosed for delivering a self-expanding prosthetic mitral valve device to the left atrium, with no engagement of the left ventricle, the native mitral valve leaflets or the annular tissue downstream of the upper annular surface during delivery, and in some embodiments with no engagement of the ventricle, mitral valve leaflets and/or annular tissue located downstream of the upper annular surface by the delivered, positioned and expanded prosthetic mitral valve device.Type: GrantFiled: January 18, 2018Date of Patent: May 19, 2020Assignee: 4C Medical Technologies, Inc.Inventors: Jeffrey W. Chambers, Gregory G. Brucker, Joseph P. Higgins, Saravana B. Kumar, Jason S. Diedering, Karl A. Kabarowski, Robert J. Thatcher, James E. Flaherty, Jeffrey R. Stone
-
Patent number: 10595992Abstract: A device for providing cardiac treatment at the left atrium of a patient's heart. The device includes a retention body and a prosthetic valve. The retention body has a shape that can be manipulated between a collapsed state and a normal or expanded state. First and second openings are defined at one side of the retention body, and a lower opening is defined at an opposite side. The prosthetic valve is carried by the retention body at the lower opening. The retention body is configured to engage a substantial portion of an interior surface of the left atrium, securing the prosthetic valve at a desired location relative to a native mitral valve (e.g., within the mitral valve or slightly spaced from the mitral valve). The first and second openings are sized and shaped so as to permit blood flow from the pulmonary veins into the interior region.Type: GrantFiled: February 19, 2016Date of Patent: March 24, 2020Assignee: 4C Medical Technologies, Inc.Inventor: Jeffrey W. Chambers